Priscilla Gates, Jade Guarnera, Karen Caeyenberghs
Cancer-related cognitive impairment is common among people diagnosed with and treated for cancer. This can be a distressing and disabling side effect for impacted individuals. The main aim of this study is to test the feasibility and acceptability of a web-based cognitive rehabilitation program, Responding to Cognitive Concerns (eReCog), in people who have received chemotherapy for aggressive lymphoma. People with low perceived cognitive function, are being recruited from a specialist cancer centre to this single-site, parallel-group, pilot randomised controlled trial. After baseline assessment, participants are randomised one-to-one to receive usual care only (a factsheet about changes in memory and thinking for people with cancer) or eReCog plus usual care. The four-week eReCog intervention consists of four online modules offering psychoeducation on cognitive impairment associated with cancer and its treatment, skills training for improving memory and attention and relaxation training. Findings from this study will inform a future, large multi-site RCT to test the effectiveness of a novel intervention to improve cognitive outcomes and quality of life.